Literature DB >> 23903094

Therapeutics: Disrupting a survival signal.

Nicola McCarthy.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23903094     DOI： 10.1038/nrc3584

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer.

Authors:  Albrecht Neesse; Kristopher K Frese; Tashinga E Bapiro; Tomoaki Nakagawa; Mark D Sternlicht; Todd W Seeley; Christian Pilarsky; Duncan I Jodrell; Suzanne M Spong; David A Tuveson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.